tirzepatide reviews weight loss vs. Semaglutide for Loss: What I Learned, What Worked, and What Didn't ~ Tirzepatide for Medical Weight Loss

The FDA prescribing information does not list hepatotoxicity as a known adverse effect, and extensive clinical trial data have not identified significant liver-related safety signals

The only indication that there may be risks associated with taking the companies products came in the last line of a long written disclaimer at the end of the ad: See website for details and important safety information. (A similar disclaimer appears at the end of the Hims ad focusing on its ED medication.) Since the controversy over the Super Bowl ad, Hims and Hers have included a disclaimer in some of their ads regarding how their compounded weight-loss products have not been approved by the FDA and require an online consultation with a licensed provided who will determine if a prescription is appropriate. But the disclaimer doesnt appear everywhere and it still refers consumers to a company website for important safety information. As for the other telehealth companies mentioned earlier, Willow does not disclose any side effects associated with its compounded GLP-1 products in the social media post shown above and requires that consumers scroll more than halfway down product pages to learn about potential health risks

Taking semaglutide without diet and lifestyle changes may negatively impact the drugs effectiveness

Tirzepatide works gradually, over days to weeks, through incretin-mediated gut-brain signaling and delayed gastric emptying

Additional benefits include supporting immune function, wound healing, hormone production, and maintenance of skin, hair, and nail healthall of which can be compromised during rapid weight loss